Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is the Immune System?01:38

What is the Immune System?

128.1K
Overview
128.1K
Humoral Immune Responses01:36

Humoral Immune Responses

83.9K
Overview
83.9K
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

1.3K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.3K
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

1.4K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.4K
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

806
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
806
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

874
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
874

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Myeloid Cell Protein Tyrosine Phosphatase 1B Drives Retinal Neurodegeneration in Diabetic Mice.

Diabetes·2026
Same author

Next generation open access visualization of neuroanatomy through 3D modeling and 3D printing.

Anatomical sciences education·2026
Same author

Infection control in the brain and the eye.

Acta ophthalmologica·2026
Same author

Therapeutic targeting of oligodendrocytes in an agent-based model of multiple sclerosis.

PLoS computational biology·2026
Same author

Challenges of access to cadavers in low- and middle-income countries (LMIC) for undergraduate medical teaching: a review and potential solutions in the form of 3D printed replicas.

3D printing in medicine·2025
Same author

Antigen-specific polyfunctional cytotoxic T cells differentiate intraocular from peripheral blood immune responses in posterior uveitis.

Clinical & translational immunology·2025

Related Experiment Video

Updated: Feb 4, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.8K

CNS infection and immune privilege.

John V Forrester1,2,3, Paul G McMenamin4, Samantha J Dando4

  • 1Division of Applied Medicine, Section of Immunology and Infection, Institute of Medical Sciences, University of Aberdeen, Scotland, UK. j.forrester@abdn.ac.uk.

Nature Reviews. Neuroscience
|October 13, 2018
PubMed
Summary
This summary is machine-generated.

The central nervous system (CNS) exhibits immune privilege, protecting pathogens from immune attack. This immune privilege may allow certain infections to persist and reactivate later.

More Related Videos

Author Spotlight: Establishing Mixed Neuronal and Glial Cell Cultures from Embryonic Mouse Brains to Study Infection and Innate Immunity
07:41

Author Spotlight: Establishing Mixed Neuronal and Glial Cell Cultures from Embryonic Mouse Brains to Study Infection and Innate Immunity

Published on: June 30, 2023

3.7K
Systemic Bacterial Infection and Immune Defense Phenotypes in Drosophila Melanogaster
10:12

Systemic Bacterial Infection and Immune Defense Phenotypes in Drosophila Melanogaster

Published on: May 13, 2015

25.3K

Related Experiment Videos

Last Updated: Feb 4, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.8K
Author Spotlight: Establishing Mixed Neuronal and Glial Cell Cultures from Embryonic Mouse Brains to Study Infection and Innate Immunity
07:41

Author Spotlight: Establishing Mixed Neuronal and Glial Cell Cultures from Embryonic Mouse Brains to Study Infection and Innate Immunity

Published on: June 30, 2023

3.7K
Systemic Bacterial Infection and Immune Defense Phenotypes in Drosophila Melanogaster
10:12

Systemic Bacterial Infection and Immune Defense Phenotypes in Drosophila Melanogaster

Published on: May 13, 2015

25.3K

Area of Science:

  • Neuroimmunology
  • Infectious Diseases
  • Pathogen Biology

Background:

  • The central nervous system (CNS) is traditionally considered immune privileged, exhibiting reduced responses to foreign antigens.
  • Despite this privilege, the CNS can mount inflammatory responses during infection.
  • Physiological and immunological barriers typically restrict pathogen entry into the brain and retina.

Purpose of the Study:

  • To review the implications of CNS immune privilege in the context of infections.
  • To investigate whether immune privilege facilitates pathogen persistence and latency within the CNS.

Main Methods:

  • Literature review of studies on CNS immune privilege and infections.
  • Analysis of pathogen interactions with CNS immune defenses.
  • Examination of mechanisms underlying latent infections in the CNS.

Main Results:

  • Pathogens breaching CNS barriers face either destructive inflammation or benefit from immune privilege.
  • Immune privilege can shield pathogens from the peripheral immune system, enabling their survival.
  • Certain pathogens exploit CNS immune privilege to establish and maintain latent infections.

Conclusions:

  • CNS immune privilege presents a dual role in infections: it can cause inflammation or protect pathogens.
  • Immune privilege is a significant factor promoting the latency and reactivation of CNS infections.
  • Understanding this dynamic is crucial for developing strategies against persistent neuro-pathogens.